Chemicals News and Research

RSS

Researchers identify new drugs to protect brain cells from neurological disease

Researchers have identified a compound that mimics one of the brain's own growth factors and can protect brain cells against damage in several animal models of neurological disease.

27 Jan 2010

Tel Aviv University expert reviews environmental triggers of common autoimmune diseases

The links between autoimmune diseases, infections, genetics and the environment are complex and mysterious. Why are people who live near airports more susceptible to autoimmune diseases like rheumatoid arthritis and lupus? How do hormones in meat trigger the onset of a disease?

27 Jan 2010

DuPont announces fourth quarter 2009 earnings

DuPont's fourth-quarter 2009 earnings were $.48 per share, compared to a fourth-quarter 2008 loss of $.70 per share. Excluding significant items, fourth-quarter 2009 earnings were $.44 per share versus a $.28 per share loss in the prior year (see Schedule B.).

27 Jan 2010

Women with higher blood levels of PBDEs take longer to become pregnant, say researchers

Women with higher blood levels of PBDEs, a type of flame retardant commonly found in household consumer products, took longer to become pregnant compared with women who have lower PBDE levels, according to a new study by researchers at the University of California, Berkeley.

27 Jan 2010

Sinobiopharma's solid dosage Perindopril production facility receives Chinese SFDA approval

Sinobiopharma, Inc. is pleased to announce that its production facility for solid dosage Perindopril has passed the required Chinese State Food and Drug Administration (SFDA) inspection and is now approved for production and marketing.

27 Jan 2010

Book highlights causes and remedies for bad breath

So, you've bought the candy, the diamond necklace, made the reservations at her favorite restaurant and had your suit cleaned and pressed. Still, even if you earn that special Valentine's Day kiss, it won't make a difference if your breath is so bad that it could motivate the dog to leave the room.

27 Jan 2010

Curemark commences CM-AT Phase III autism clinical trial enrollment at ten sites

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company is now enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at ten sites across the country.

27 Jan 2010

Dermatological nuisance caused by toilet seats making a comeback in pediatricians' offices

Considered a dermatological nuisance that was long gone, skin irritations caused by toilet seats appear to be making a comeback in pediatricians' offices, according to research led by Johns Hopkins Children's Center investigator Bernard Cohen, M.D.

25 Jan 2010

Mitchell Group's clinically proven cosmetic products focus customer's safety above anything else

Mitchell Group, a global manufacturer and distributor of clinically proven and locally inspired cosmetic and beauty products, puts their customer's safety above anything else.

23 Jan 2010

Kalorama report predicts double-digit growth in SNP market

A setback in the scientific basis for SNP (single nucleotide polymorphisms) analysis may turn out to be a blessing in disguise for makers of genotyping equipment, reagents and software, according to Kalorama Information.

23 Jan 2010

Long-term health effects of e-cigarettes: More research needed

The need for more research into the long-term health effects of electronic cigarettes has been highlighted by scientists in the British Medical Journal.

22 Jan 2010

Ontario must stay the course in the fight against lung cancer

Currently an estimated 7,800 Ontarians are diagnosed with lung cancer and approximately 6,000 die of the disease each year. Smoking and exposure to second-hand smoke continue to be the main risk factors for developing lung cancer - and that is why we must continue to encourage Ontarians to be smoke-free.

21 Jan 2010

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

With seed money from the National Science Foundation (NSF), bioengineers from the University of California, Berkeley, and Stanford University are ramping up efforts to characterize the thousands of control elements critical to the engineering of microbes so that eventually, researchers can mix and match these "DNA parts" in synthetic organisms to produce new drugs, fuels or chemicals.

21 Jan 2010

Study links thyroid disease with human exposure to PFOA

A study by the University of Exeter and the Peninsula Medical School for the first time links thyroid disease with human exposure to perfluorooctanoic acid (PFOA). PFOA is a persistent organic chemical used in industrial and consumer goods including nonstick cookware and stain- and water-resistant coatings for carpets and fabrics.

21 Jan 2010

Covidien announces results for first-quarter of fiscal 2010

Covidien plc today reported results for the first quarter of fiscal 2010 (October – December 2009). First-quarter net sales of $2.7 billion were up 7% from the $2.6 billion reported a year ago, with favorable foreign exchange of $121 million increasing the quarterly sales growth rate by approximately 5 percentage points.

20 Jan 2010

Novel approach could speed up discovery for new psychiatric drugs

Researchers from the University of British Columbia and Harvard University have co-developed a system that captures on video and barcodes the behavioral responses of zebrafish to chemical compounds on a large scale. The approach could dramatically speed up the discovery of new psychiatric drugs.

20 Jan 2010

HSF1A stimulates more protein chaperones and reduces protein misfolding

Scientists at Duke University Medical Center have found some compounds that improve a cell's ability to properly "fold" proteins and could lead to promising drugs for degenerative nerve diseases, including Huntington's disease, Alzheimer's disease and Parkinson's disease.

20 Jan 2010

Prenatal exposure to PBDEs associated with neurodevelopmental effects in young children

Prenatal exposure to ambient levels of flame retardant compounds called polybrominated diphenyl ethers (PBDEs) is associated with adverse neurodevelopmental effects in young children, according to researchers at the Columbia Center for Children's Environmental Health (CCCEH) at Columbia University's Mailman School of Public Health.

20 Jan 2010

LABEC Pharma meets European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test

Interleukin Genetics, Inc. and LABEC Pharma, S.L. announced today that LABEC Pharma has met European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test. The test, which helps to identify individuals at elevated risk for early heart attack, will be marketed to physicians in Spain and Portugal by LABEC Pharma under the product name Cardio Health™.

20 Jan 2010

Thermo Fisher Scientific signs definitive agreement to acquire Ahura Scientific

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Ahura Scientific, a leader in field-deployed analytical instruments for human health and public safety, for $145 million in cash plus the potential for an earn-out payment based on the achievement of certain 2010 financial targets.

From Thermo Fisher Scientific Inc. 19 Jan 2010

Chemicals News and Research

Researchers identify new drugs to protect brain cells from neurological disease

Tel Aviv University expert reviews environmental triggers of common autoimmune diseases

DuPont announces fourth quarter 2009 earnings

Women with higher blood levels of PBDEs take longer to become pregnant, say researchers

Sinobiopharma's solid dosage Perindopril production facility receives Chinese SFDA approval

Book highlights causes and remedies for bad breath

Curemark commences CM-AT Phase III autism clinical trial enrollment at ten sites

Dermatological nuisance caused by toilet seats making a comeback in pediatricians' offices

Mitchell Group's clinically proven cosmetic products focus customer's safety above anything else

Kalorama report predicts double-digit growth in SNP market

Long-term health effects of e-cigarettes: More research needed

Ontario must stay the course in the fight against lung cancer

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

Study links thyroid disease with human exposure to PFOA

Covidien announces results for first-quarter of fiscal 2010

Novel approach could speed up discovery for new psychiatric drugs

HSF1A stimulates more protein chaperones and reduces protein misfolding

Prenatal exposure to PBDEs associated with neurodevelopmental effects in young children

LABEC Pharma meets European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test

Thermo Fisher Scientific signs definitive agreement to acquire Ahura Scientific

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery